Accelerating the Path from Discovery to Drug

Dr. Roy Stevens. Department of Endodontology, and others discussing ways to expedite new drugs development

04/17/2017 Professor Roy Stevens, Department of Endodontology, is one of several Temple scientists working with Janseen Pharmaceuticals to bring treatments to the market faster.

The collaboration between Temple and Janseen began with Dr. Stevens impressing Janssen scientists and strategists with his work researching phage therapy as a potential treatment for antibiotic-resistant infections.

http://news.temple.edu/news/2016-12-06/janssen-partnership